0001628908-23-000107.txt : 20230630 0001628908-23-000107.hdr.sgml : 20230630 20230630162719 ACCESSION NUMBER: 0001628908-23-000107 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230628 FILED AS OF DATE: 20230630 DATE AS OF CHANGE: 20230630 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Blackley Seth CENTRAL INDEX KEY: 0001643346 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37415 FILM NUMBER: 231062120 MAIL ADDRESS: STREET 1: 800 N. GLEBE ROAD, SUITE 500 CITY: ARLINGTON STATE: VA ZIP: 22203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Evolent Health, Inc. CENTRAL INDEX KEY: 0001628908 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT SERVICES [8741] IRS NUMBER: 320454912 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 800 NORTH GLEBE RD, SUITE 500 CITY: ARLINGTON STATE: VA ZIP: 22203 BUSINESS PHONE: 571-389-6000 MAIL ADDRESS: STREET 1: 800 NORTH GLEBE RD, SUITE 500 CITY: ARLINGTON STATE: VA ZIP: 22203 4 1 wf-form4_168815682764495.xml FORM 4 X0407 4 2023-06-28 0 0001628908 Evolent Health, Inc. EVH 0001643346 Blackley Seth C/O EVOLENT HEALTH, INC. 800 N. GLEBE ROAD, SUITE 500 ARLINGTON VA 22203 1 1 0 0 Chief Executive Officer 1 Class A Common Stock 2023-06-28 4 M 0 33011 3.84 A 816022 D Class A Common Stock 2023-06-28 4 S 0 24542 30.65 D 791480 D Class A Common Stock 2023-06-28 4 S 0 8469 31.15 D 783011 D Class A Common Option (right to buy) 3.84 2023-06-28 4 M 0 33011 0 D 2024-04-01 Class A Common Stock 33011.0 0 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2023. Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.02 to $31.01, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.02 to $31.30, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The Class A Common Stock Options exercised vested on December 1, 2017. /s/ Jonathan Weinberg, Attorney-in-fact 2023-06-30